Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1550160
PUBLISHER: BCC Research | PRODUCT CODE: 1550160
Global Multiomics Market
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.
The global market for multiomics for consumables is expected to grow from $1.6 billion in 2024 and is projected to reach $3.1 billion by the end of 2029, at a CAGR of 14.1% during the forecast period of 2024 to 2029.
The global market for multiomics for instruments is expected to grow from $629.9 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.
Report Scope:
This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.
Report Includes:
- 51 data tables and 55 additional tables
- An analysis of the current and future global markets for multiomics
- Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
- Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
- Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
- Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
- Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding.
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.
Product Code: BIO260A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Technology Background
- Omics Types
- Various Multiomics Approaches and Applications
- Technological Infrastructure and Data Integration
- PESTEL Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
- Regulatory Landscape
- Federal Regulation
- CMS Regulation
- U.S. Food and Drug Administration Regulation
- U.S. Federal Trade Commission Regulation
- Strategic Recommendations
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Rapid Advances in Multiomics Research and its Applications
- Favorable Funding Scenario for Multiomics Research Activities
- Decrease in DNA-Sequencing Method Prices
- Growing Prevalence of Cancer Generating Demand for Personalized Treatments
- Promising Applications of Multiomics in the Drug Development Process
- Market Restraints
- Lack of Data Standardization
- Market Opportunities
- Expanding Single-Cell Multiomics Applications
Chapter 4 Emerging Technologies and Developments
- Artificial Intelligence in Multiomics
- Companies in the Artificial Intelligence Multiomics Market
- Advances in Single-Cell Omics and Multiomics
Chapter 5 Market Segmentation Analysis
- Key Market Trends
- Segmentation Breakdown
- Global Market for Multiomics by Product
- Instruments
- Consumables
- Software and Services
- Global Market for Multiomics by Platform
- Genomics
- Proteomics
- Transcriptomics
- Metabolomics
- Other Platforms
- Global Market for Multiomics by Application
- Oncology
- Immunology
- Neurology
- Cell Biology
- Other Applications
- Global Market for Multiomics by End User
- Academic Research Organizations
- Pharmaceutical and Biotechnology Companies
- Clinical and Hospital Laboratories
- Other End Users
- Geographic Breakdown
- Global Multiomics Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Top Players Ranking
- Key Strategies Adopted by Players
- Collaborations and Partnerships
- New Product Launches
- Expansions and Investments
- Mergers and Acquisitions
- Agreements
- Patent Analysis
Chapter 7 Sustainability in Multiomics Market: ESG Perspective
- Introduction to ESG
- ESG Performance in Market
- ESG Practices in the Multiomics Industry
- Concluding Remarks from BCC Research
Chapter 8 Appendix
- Methodology
- Acronyms
- References
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
- BIO-RAD LABORATORIES INC.
- BD
- BRUKER
- BGI
- F. HOFFMANN-LA ROCHE LTD.
- ILLUMINA INC.
- QIAGEN
- REVVITY
- STANDARD BIOTOOLS
- THERMO FISHER SCIENTIFIC INC.
Product Code: BIO260A
List of Tables
- Summary Table A : Global Market for Multiomics, by Product, Through 2029
- Summary Table B : Global Market for Multiomics, by Region, Through 2029
- Table 1 : Multiomics Approaches and Their Molecular Readouts
- Table 2 : Molecular Biology Technologies for Multiomics Approaches
- Table 3 : Single-Cell and Spatial Omics Technologies, 2018-2023
- Table 4 : Publicly Available Omics Data in the Cancer Research Field
- Table 5 : Multiomics' Role During Various Stages of Drug Development Process
- Table 6 : Companies in the Artificial Intelligence Multiomics Market
- Table 7 : Global Market for Multiomics, by Product, Through 2029
- Table 8 : Global Market for Multiomics for Instruments, by Region, Through 2029
- Table 9 : Global Market for Multiomics for Consumables, by Region, Through 2029
- Table 10 : Global Market for Multiomics for Software and Services, by Region, Through 2029
- Table 11 : Global Market for Multiomics, by Platform, Through 2029
- Table 12 : Global Market for Multiomics for Genomics, by Region, Through 2029
- Table 13 : Global Market for Multiomics for Proteomics, by Region, Through 2029
- Table 14 : Global Market for Multiomics for Transcriptomics, by Region, Through 2029
- Table 15 : Global Market for Multiomics for Metabolomics, by Region, Through 2029
- Table 16 : Global Market for Multiomics for Other Platforms, by Region, Through 2029
- Table 17 : Global Market for Multiomics, by Application, Through 2029
- Table 18 : Global Market for Multiomics for Oncology, by Region, Through 2029
- Table 19 : Global Market for Multiomics for Immunology, by Region, Through 2029
- Table 20 : Global Market for Multiomics for Neurology, by Region, Through 2029
- Table 21 : Global Market for Multiomics for Cell Biology, by Region, Through 2029
- Table 22 : Global Market for Multiomics for Other Applications, by Region, Through 2029
- Table 23 : Global Market for Multiomics, by End User, Through 2029
- Table 24 : Global Market for Multiomics for Academic Research Organizations, by Region, Through 2029
- Table 25 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
- Table 26 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, Through 2029
- Table 27 : Global Market for Multiomics for Other End Users, by Region, Through 2029
- Table 28 : Global Market for Multiomics, by Region, Through 2029
- Table 29 : North American Market for Multiomics, by Product, Through 2029
- Table 30 : North American Market for Multiomics, by Platform, Through 2029
- Table 31 : North American Market for Multiomics, by Application, Through 2029
- Table 32 : North American Market for Multiomics, by End User, Through 2029
- Table 33 : European Initiatives Focused on Omics Research for Personalized Medicine
- Table 34 : European Market for Multiomics, by Product, Through 2029
- Table 35 : European Market for Multiomics, by Platform, Through 2029
- Table 36 : European Market for Multiomics, by Application, Through 2029
- Table 37 : European Market for Multiomics, by End User, Through 2029
- Table 38 : Asia-Pacific Market for Multiomics, by Product, Through 2029
- Table 39 : Asia-Pacific Market for Multiomics, by Platform, Through 2029
- Table 40 : Asia-Pacific Market for Multiomics, by Application, Through 2029
- Table 41 : Asia-Pacific Market for Multiomics, by End User, Through 2029
- Table 42 : Rest of the World Market for Multiomics, by Product, Through 2029
- Table 43 : Rest of the World Market for Multiomics, by Platform, Through 2029
- Table 44 : Rest of the World Market for Multiomics, by Application, Through 2029
- Table 45 : Rest of the World Market for Multiomics, by End User, Through 2029
- Table 46 : Top Players in Multiomics Market, 2023
- Table 47 : Collaborations and Partnerships: Multiomics Market, 2021-2024
- Table 48 : New Product Launches: Multiomics Market, 2021-2024
- Table 49 : Expansions and Investments: Multiomics Market, 2021-2024
- Table 50 : Mergers and Acquisitions: Multiomics Market, 2020-2024
- Table 51 : Agreements: Multiomics Market, 2022-2024
- Table 52 : Multiomics Market: Patent Analysis, 2018-2023
- Table 53 : Key Focus Areas in ESG Metrics
- Table 54 : Environmental Performance Initiatives in the Multiomics Market, 2022 and 2023
- Table 55 : Social Performance Initiatives in the Multiomics Market, 2022 and 2023
- Table 56 : Governance Performance Initiatives in the Multiomics Market, 2022 and 2023
- Table 57 : ESG Rankings for Multiomics Companies, 2024*
- Table 58 : Acronyms Used in this Report
- Table 59 : Agilent Technologies Inc.: Company Snapshot
- Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
- Table 61 : Agilent Technologies Inc.: Product Portfolio
- Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
- Table 63 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
- Table 64 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
- Table 65 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2023
- Table 66 : Bio-Rad Laboratories Inc.: Company Snapshot
- Table 67 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
- Table 68 : Bio-Rad Laboratories Inc.: Product Portfolio
- Table 69 : Bio-Rad Laboratories Inc.: News/Key Developments, 2020
- Table 70 : BD: Company Snapshot
- Table 71 : BD: Financial Performance, FY 2022 and 2023
- Table 72 : BD: Product Portfolio
- Table 73 : BD: News/Key Developments, 2024
- Table 74 : Bruker: Company Snapshot
- Table 75 : Bruker: Financial Performance, FY 2022 and 2023
- Table 76 : Bruker: Product Portfolio
- Table 77 : Bruker: News/Key Developments, 2024
- Table 78 : BGI: Company Snapshot
- Table 79 : BGI: Product Portfolio
- Table 80 : BGI: News/Key Developments, 2024
- Table 81 : F. Hoffmann-La Roche Ltd.: Company Snapshot
- Table 82 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
- Table 83 : F. Hoffman-La Roche Ltd.: Product Portfolio
- Table 84 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2022
- Table 85 : Illumina Inc.: Company Snapshot
- Table 86 : Illumina Inc.: Financial Performance, FY 2022 and 2023
- Table 87 : Illumina Inc.: Product Portfolio
- Table 88 : Illumina Inc.: News/Key Developments, 2023
- Table 89 : QIAGEN: Company Snapshot
- Table 90 : QIAGEN: Financial Performance, FY 2022 and 2023
- Table 91 : QIAGEN: Product Portfolio
- Table 92 : QIAGEN: News/Key Developments, 2024
- Table 93 : Revvity: Company Snapshot
- Table 94 : Revvity: Financial Performance, FY 2022 and 2023
- Table 95 : Revvity: Product Portfolio
- Table 96 : Revvity: News/Key Developments, 2023
- Table 97 : Standard BioTools: Company Snapshot
- Table 98 : Standard BioTools: Financial Performance, FY 2022 and 2023
- Table 99 : Standard BioTools: Product Portfolio
- Table 100 : Standard BioTools: News/Key Developments, 2024
- Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
- Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
List of Figures
- Summary Figure A : Global Market for Multiomics, by Product, 2021-2029
- Summary Figure B : Global Market for Multiomics, by Region, 2021-2029
- Figure 1 : Omics Types
- Figure 2 : Applications of Multiomics Approaches
- Figure 3 : PESTEL Analysis: Multiomics Market
- Figure 4 : Strategic Recommendations: Multiomics Market
- Figure 5 : Multiomics Market Dynamics
- Figure 6 : Average Cost Per Genome: Year-on-Year Trend, 2011-2022
- Figure 7 : Global Market Shares for Multiomics, by Product, 2024
- Figure 8 : Global Market for Multiomics for Instruments, by Region, 2021-2029
- Figure 9 : Global Market for Multiomics for Consumables, by Region, 2021-2029
- Figure 10 : Global Market for Multiomics for Software and Services, by Region, 2021-2029
- Figure 11 : Global Market Shares for Multiomics, by Platform, 2024
- Figure 12 : Global Market for Multiomics for Genomics, by Region, 2021-2029
- Figure 13 : Global Market for Multiomics for Proteomics, by Region, 2021-2029
- Figure 14 : Global Market for Multiomics for Transcriptomics, by Region, 2021-2029
- Figure 15 : Global Market for Multiomics for Metabolomics, by Region, 2021-2029
- Figure 16 : Global Market for Multiomics for Other Platforms, by Region, 2021-2029
- Figure 17 : Major Applications of Multiomics
- Figure 18 : Global Market Shares for Multiomics, by Application, 2024
- Figure 19 : Global Market for Multiomics for Oncology, by Region, 2021-2029
- Figure 20 : Global Market for Multiomics for Immunology, by Region, 2021-2029
- Figure 21 : Global Market for Multiomics for Neurology, by Region, 2021-2029
- Figure 22 : Global Market for Multiomics for Cell Biology, by Region, 2021-2029
- Figure 23 : Global Market for Multiomics for Other Applications, by Region, 2021-2029
- Figure 24 : Global Market Shares for Multiomics, by End User, 2024
- Figure 25 : Global Market for Multiomics for Academic Research Organizations, by Region, 2021¬-2029
- Figure 26 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
- Figure 27 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, 2021-2029
- Figure 28 : Global Market for Multiomics for Other End Users, by Region, 2021-2029
- Figure 29 : Global Market Shares of Multiomics, by Region, 2024
- Figure 30 : North American Market for Multiomics, by Product, 2021-2029
- Figure 31 : North American Market for Multiomics, by Platform, 2021-2029
- Figure 32 : North American Market for Multiomics, by Application, 2021-2029
- Figure 33 : North American Market for Multiomics, by End User, 2021-2029
- Figure 34 : European Market for Multiomics, by Product, 2021-2029
- Figure 35 : European Market for Multiomics, by Platform, 2021-2029
- Figure 36 : European Market for Multiomics, by Application, 2021-2029
- Figure 37 : European Market for Multiomics, by End User, 2021-2029
- Figure 38 : Asia-Pacific Multiomics Market Growth Drivers
- Figure 39 : Asia-Pacific Market for Multiomics, by Product, 2021-2029
- Figure 40 : Asia-Pacific Market for Multiomics, by Platform, 2021-2029
- Figure 41 : Asia-Pacific Market for Multiomics, by Application, 2021-2029
- Figure 42 : Asia-Pacific Market for Multiomics, by End User, 2021-2029
- Figure 43 : Rest of the World Market for Multiomics, by Product, 2021-2029
- Figure 44 : Rest of the World Market for Multiomics, by Platform, 2021-2029
- Figure 45 : Rest of the World Market for Multiomics, by Application, 2021-2029
- Figure 46 : Rest of the World Market for Multiomics, by End User, 2021-2029
- Figure 47 : Global Multiomics Market Competitive Intelligence, 2020-2024
- Figure 48 : Patents, 2018-2023
- Figure 49 : How a Strong ESG Proposition Benefits Businesses
- Figure 50 : Biotech Companies Providing ESG Disclosure, 2022
- Figure 51 : Location of ESG Disclosure, 2022
- Figure 52 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 53 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 54 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 55 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 56 : BD: Revenue Share, by Business Unit, FY 2023
- Figure 57 : BD: Revenue Share, by Country/Region, FY 2023
- Figure 58 : Bruker: Revenue Share, by Business Unit, FY 2023
- Figure 59 : Bruker: Revenue Share, by Country/Region, FY 2023
- Figure 60 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
- Figure 61 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
- Figure 62 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 63 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 64 : QIAGEN: Revenue Share, by Business Unit, FY 2023
- Figure 65 : QIAGEN: Revenue Share, by Country/Region, FY 2023
- Figure 66 : Revvity: Revenue Share, by Business Unit, FY 2023
- Figure 67 : Revvity: Revenue Share, by Country/Region, FY 2023
- Figure 68 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
- Figure 69 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
- Figure 70 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 71 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.